Lidoderm Patch (lidocaine patch 5% )
Company: Hind Health Care
Approval Status: Approved June 1999
Treatment for: Neurology
Areas: Neurology
General Information
Other Useful Resources
Lidoderm Patch has been approved for the treatment of post-herpetic neuralgia.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
